Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
38
MTB Quote, Financials, Valuation and Earnings
Last price:
$189.06
Seasonality move
:
8.28%
Day range:
$184.22 - $190.32
52-week range:
$128.31 - $225.70
Dividend yield:
2.82%
P/E ratio:
14.03x
P/S ratio:
3.46x
P/B ratio:
1.19x
Volume:
3M
Avg. volume:
1.1M
1-year change:
41.45%
Market cap:
$31.4B
Revenue:
$9.4B
EPS (TTM):
$13.51
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.2B | $6B | $6B | $8B | $9.4B | |
| Revenue Growth (YoY) | 4.45% | -3.83% | 0.12% | 34.4% | 17.28% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2B | $2.1B | $2.2B | $3B | $3.2B | |
| Other Inc / (Exp) | $18M | -$9.4M | -$21M | -$6M | $229M | |
| Operating Expenses | $2.1B | $2.1B | $2.1B | $2.6B | $3.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.5B | $1.8B | $2.5B | $2.6B | $3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $618.1M | $416.4M | $596M | $620M | $878M | |
| Net Income to Company | $1.9B | $1.4B | $1.9B | $2B | $2.7B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.9B | $1.4B | $1.9B | $2B | $2.7B | |
| Basic EPS (Cont. Ops) | $13.76 | $9.94 | $13.81 | $11.59 | $15.85 | |
| Diluted EPS (Cont. Ops) | $13.75 | $9.94 | $13.80 | $11.53 | $15.79 | |
| Weighted Average Basic Share | $134.4M | $128.6M | $128.6M | $163.2M | $166.4M | |
| Weighted Average Diluted Share | $134.5M | $128.7M | $128.8M | $164M | $167M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.3B | $2.1B | $2.6B | $3B | $6.7B | |
| Revenue (Reported) | $6.2B | $6B | $6B | $8B | $9.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.3B | $2.1B | $2.6B | $3B | $6.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $2.2B | $2.3B | $2.3B | |
| Revenue Growth (YoY) | -6.04% | 4.97% | 45.91% | 4.16% | -0.13% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $502.9M | $544.4M | $785.9M | $779M | $827M | |
| Other Inc / (Exp) | $2.8M | $291K | -$1.1M | -- | -$2M | |
| Operating Expenses | $506.8M | $538.4M | $751.2M | $794M | $839M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $486.9M | $657M | $847.5M | $907M | $909M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $114.7M | $161.6M | $200.9M | $217M | $188M | |
| Net Income to Company | $372.1M | $495.5M | $646.6M | $690M | $721M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $372.1M | $495.5M | $646.6M | $690M | $721M | |
| Basic EPS (Cont. Ops) | $2.75 | $3.70 | $3.55 | $4.00 | $4.04 | |
| Diluted EPS (Cont. Ops) | $2.75 | $3.69 | $3.53 | $3.98 | $4.02 | |
| Weighted Average Basic Share | $128.3M | $128.7M | $174.6M | $165.9M | $166.7M | |
| Weighted Average Diluted Share | $128.4M | $128.8M | $175.7M | $166.6M | $167.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $544.9M | $682.7M | $950.3M | $1.8B | $2B | |
| Revenue (Reported) | $1.5B | $1.5B | $2.2B | $2.3B | $2.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $544.9M | $682.7M | $950.3M | $1.8B | $2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.9B | $6B | $7.2B | $9.7B | $9.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $2.1B | $2.8B | $3.2B | $3.3B | |
| Other Inc / (Exp) | -$17.5M | -$21M | -$267K | -$3.1M | -$4M | |
| Operating Expenses | $2.1B | $2.1B | $2.3B | $3.4B | $3.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.8B | $2.5B | $2.2B | $4B | $3.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $426.1M | $603.8M | $515.8M | $978.8M | $665M | |
| Net Income to Company | $1.4B | $1.9B | $1.7B | $3B | $2.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.4B | $1.9B | $1.7B | $3B | $2.4B | |
| Basic EPS (Cont. Ops) | $10.02 | $13.96 | $10.63 | $17.42 | $13.58 | |
| Diluted EPS (Cont. Ops) | $10.02 | $13.95 | $10.60 | $17.33 | $13.51 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.3B | $2.6B | $2.4B | $6.3B | $7.3B | |
| Revenue (Reported) | $5.9B | $6B | $7.2B | $9.7B | $9.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.3B | $2.6B | $2.4B | $6.3B | $7.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4.5B | $5.7B | $7.3B | $6.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.6B | $2.2B | $2.4B | $2.6B | |
| Other Inc / (Exp) | -$11M | -$22.6M | -$1.9M | $1M | -$8M | |
| Operating Expenses | $1.6B | $1.6B | $1.7B | $2.5B | $2.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.1B | $1.9B | $1.6B | $3B | $2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $267M | $454.4M | $374.2M | $733M | $521M | |
| Net Income to Company | $882M | $1.4B | $1.2B | $2.3B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $882M | $1.4B | $1.2B | $2.3B | $1.9B | |
| Basic EPS (Cont. Ops) | $6.42 | $10.44 | $7.26 | $13.10 | $10.83 | |
| Diluted EPS (Cont. Ops) | $6.42 | $10.43 | $7.23 | $13.04 | $10.77 | |
| Weighted Average Basic Share | $386.3M | $385.9M | $480.9M | $499.5M | $500.1M | |
| Weighted Average Diluted Share | $386.4M | $386.4M | $483.4M | $501.3M | $502.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $1.9B | $1.8B | $5.1B | $5.6B | |
| Revenue (Reported) | $4.4B | $4.5B | $5.7B | $7.3B | $6.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.4B | $1.9B | $1.8B | $5.1B | $5.6B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.6B | $25.2B | $43.2B | $26.5B | $29.8B | |
| Short Term Investments | $6.3B | $4.8B | $4B | $10.7B | $5B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $16.4B | $31.3B | $48.3B | $39.8B | $37.6B | |
| Property Plant And Equipment | $1.1B | $1.2B | $1.1B | $1.7B | $1.7B | |
| Long-Term Investments | $10B | $8.1B | $7.2B | $25.3B | $27B | |
| Goodwill | $4.6B | $4.6B | $4.6B | $8.5B | $8.5B | |
| Other Intangibles | $29M | $14.2M | $4M | $209M | $147M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $119.9B | $142.6B | $155.1B | $200.7B | $208.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $3.2B | $5B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $164M | $59.5M | $47M | $3.6B | $5.3B | |
| Long-Term Debt | $6.9B | $4.4B | $3.5B | $4B | $8.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $104.2B | $126.4B | $137.2B | $175.4B | $181.3B | |
| Common Stock | $1.3B | $1.3B | $1.8B | $2.1B | $2.1B | |
| Other Common Equity Adj | -$206.7M | -$63M | -$127.6M | -$790M | -$459M | |
| Common Equity | $14.5B | $14.9B | $16.2B | $23.3B | $24.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $15.7B | $16.2B | $17.9B | $25.3B | $27B | |
| Total Liabilities and Equity | $119.9B | $142.6B | $155.1B | $200.7B | $208.3B | |
| Cash and Short Terms | $14.9B | $30B | $47.2B | $37.2B | $34.8B | |
| Total Debt | $6.9B | $4.4B | $3.5B | $7.2B | $13.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $21.7B | $39.9B | $27.6B | $31.9B | $26.6B | |
| Short Term Investments | $5.2B | $3.5B | $3.3B | $7.3B | $12.5B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $26.9B | $43.4B | $31B | $39.1B | $39.2B | |
| Property Plant And Equipment | $1.1B | $1.1B | $1.6B | $1.7B | $1.7B | |
| Long-Term Investments | $8.9B | $7.1B | $24.7B | $27.5B | $32.4B | |
| Goodwill | $4.6B | $4.6B | $8.5B | $8.5B | $8.5B | |
| Other Intangibles | $17.3M | $6M | $227M | $162.3M | $107M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $138.6B | $151.9B | $198B | $209.1B | $211.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $46.1M | $103.5M | $917.8M | $6.2B | $2.5B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $46.1M | $103.5M | $917.8M | $6.7B | $2.6B | |
| Long-Term Debt | $5.5B | $3.5B | $3.5B | $7.1B | $11.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $122.5B | $134.4B | $172.7B | $182.9B | $182.9B | |
| Common Stock | $1.3B | $1.8B | $2.1B | $2.1B | $2.5B | |
| Other Common Equity Adj | $175.5M | -$210.4M | -$900M | -$941.9M | -$27M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | $495M | -- | -- | -$350M | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $16.1B | $17.5B | $25.3B | $26.2B | $28.9B | |
| Total Liabilities and Equity | $138.6B | $151.9B | $198B | $209.1B | $211.8B | |
| Cash and Short Terms | $26.9B | $43.4B | $31B | $39.1B | $39.2B | |
| Total Debt | $5.5B | $3.6B | $4.4B | $13.3B | $14.1B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $1.4B | $1.9B | $2B | $2.7B | |
| Depreciation & Amoritzation | $301.3M | $320.3M | $324M | $435M | $497M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $789.2M | $2.7B | $4.6B | $3.9B | |
| Capital Expenditures | $178M | $172.3M | $149M | $214M | $256M | |
| Cash Acquisitions | -- | -- | -- | $394M | -- | |
| Cash From Investing | $727M | -$22B | -$13.6B | $16.6B | -$7.9B | |
| Dividends Paid (Ex Special Dividend) | -$619.6M | -$636.4M | -$648M | -$881M | -$968M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $10M | $999M | $5B | |
| Long-Term Debt Repaid | -$1.6B | -$2.7B | -$853M | -$907M | -$824M | |
| Repurchase of Common Stock | -$1.7B | -$373.8M | -- | -$1.8B | -$594M | |
| Other Financing Activities | -$25.4M | -$11.4M | -$28M | -$14M | $18M | |
| Cash From Financing | -$3.3B | $21.3B | $10.7B | -$21B | $4.2B | |
| Beginning Cash (CF) | $1.6B | $1.4B | $1.6B | $1.3B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$169.1M | $116.4M | -$215M | $182M | $211M | |
| Ending Cash (CF) | $1.4B | $1.6B | $1.3B | $1.5B | $1.7B | |
| Levered Free Cash Flow | $2.2B | $616.9M | $2.6B | $4.4B | $3.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $372.1M | $495.5M | $646.6M | $690M | $721M | |
| Depreciation & Amoritzation | $85.5M | $84.4M | $127.3M | $130M | $122M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6M | $486.3M | $1.1B | $1.4B | -$28M | |
| Capital Expenditures | $31.7M | $42.7M | $39.1M | $67M | $30M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $967.3M | -$1.2B | $6.2B | -$1.9B | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$162.8M | -$163M | -$242.7M | -$249M | -$274M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $9.5M | $499.3M | $546M | $646M | |
| Long-Term Debt Repaid | -$850.6M | -$49K | -$7.1M | -$781M | -$516M | |
| Repurchase of Common Stock | -- | -- | -$600M | -- | -$548M | |
| Other Financing Activities | -$2.9M | -$7.5M | $25.4M | $6M | $60M | |
| Cash From Financing | -$826.8M | $778.7M | -$6.8B | $408M | $1.9B | |
| Beginning Cash (CF) | $1.4B | $1.4B | $1.7B | $1.8B | $1.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $134.4M | $69.2M | $567.5M | -$79M | $438M | |
| Ending Cash (CF) | $1.5B | $1.5B | $2.3B | $1.8B | $2.2B | |
| Levered Free Cash Flow | -$37.7M | $443.6M | $1.1B | $1.4B | -$58M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.4B | $1.9B | $1.7B | $3B | $2.4B | |
| Depreciation & Amoritzation | $317.3M | $323.7M | $413.5M | $470.1M | $508M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.3B | $2.7B | $4.3B | $4.1B | $2.7B | |
| Capital Expenditures | $183.9M | $134.1M | $188.6M | $255.2M | $219M | |
| Cash Acquisitions | -- | -- | $393.9M | $77K | -- | |
| Cash From Investing | -$13.3B | -$14.2B | $16.8B | -$12.2B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$639.6M | -$635.6M | -$826.6M | -$956.4M | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $499.8M | $4.5B | $5B | |
| Long-Term Debt Repaid | -$1.6B | -$1.9B | -$907.2M | -$780.8M | -$721M | |
| Repurchase of Common Stock | -$656M | -- | -$1.2B | -$1.2B | -$548M | |
| Other Financing Activities | -$17.4M | -$21.3M | -$9.2M | -$14.8M | $119M | |
| Cash From Financing | $11.7B | $11.5B | -$20.3B | $7.7B | -$127M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$329.8M | -$9.5M | $776.3M | -$487.2M | $447M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.1B | $2.5B | $4.1B | $3.8B | $2.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $882M | $1.4B | $1.2B | $2.3B | $1.9B | |
| Depreciation & Amoritzation | $240.1M | $243.4M | $332.9M | $368M | $379M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $125.1M | $2B | $3.6B | $3.1B | $1.9B | |
| Capital Expenditures | $125.4M | $87.2M | $126.8M | $168M | $131M | |
| Cash Acquisitions | -- | -- | $393.9M | -- | -- | |
| Cash From Investing | -$18B | -$10.2B | $20.3B | -$8.6B | -$2.8B | |
| Dividends Paid (Ex Special Dividend) | -$481.6M | -$480.9M | -$659.6M | -$735M | -$778M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $9.5M | $499.3M | $4B | $4B | |
| Long-Term Debt Repaid | -$1.6B | -$853M | -$907.2M | -$781M | -$678M | |
| Repurchase of Common Stock | -$373.8M | -- | -$1.2B | -$594M | -$548M | |
| Other Financing Activities | -$13.2M | -$23M | -$4.2M | -$5M | $96M | |
| Cash From Financing | $17.9B | $8.1B | -$23B | $5.7B | $1.4B | |
| Beginning Cash (CF) | $4.1B | $4.2B | $4.4B | $5.2B | $5.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $52.9M | -$73M | $918.2M | $249M | $485M | |
| Ending Cash (CF) | $4.1B | $4.2B | $5.4B | $5.4B | $5.7B | |
| Levered Free Cash Flow | -$305K | $1.9B | $3.5B | $2.9B | $1.8B | |
Get MTB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MTB
Sector
P/E ratio
14.03x
12.02x
PEG ratio
0.67x
0.36x
P/B ratio
1.19x
1.05x
Price / LTM sales
3.46x
2.55x
Growth Metrics
MTB
Sector
Revenue growth
-0.13%
6.08%
Earnings growth
1.01%
6.45%
Revenue (5-year growth)
9.65%
5.85%
Earnings forecast
$3.62
$0.56
Profitability
MTB
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
5.69%
5.27%
Return on assets
1.13%
0.98%
Return on equity
8.68%
9.43%
Earnings Date
Last Earnings Date
Oct
17
Next Earnings Date
Jan
16
Estimated Next Earnings Date
Jan
16
Balance Sheet
MTB
Sector
Total cash
$39.2B
$617M
Short term investments
$5B
$408.4M
Total assets
$208.3B
$4.5B
Long term debt
$14.1B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.8% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.65% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
